Logo

    Talking Enterprise Imaging at RSNA 2022

    enDecember 02, 2022
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    Join AXIS Imaging News Chief Editor Keri Stephens as she talks to Tracy Byers, senior vice president and general manager of enterprise imaging at Change Healthcare. The in-person interview, conducted at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, delves into all things enterprise imaging and why cloud-native solutions are especially beneficial.

    Particularly, Byers shares the impetus behind Change Healthcare’s introduction of Stratus Cloud PACS and the cybersecurity implications of the launch. After all, Byers maintains, hospital chief information officers lie awake at night wondering when—not if—they’re going to get hacked.

    Recent Episodes from The MEDQOR Podcast Network

    Direct 3D-Printed Aligners Redefine Treatment Possibilities A Deep Dive with Dr Ki Beom Kim

    Direct 3D-Printed Aligners Redefine Treatment Possibilities A Deep Dive with Dr Ki Beom Kim

    Innovation is rampant in orthodontics—to the point that we’re seeing innovation within innovation. Take 3D printing, for example. The 3D printer alone—just the printer itself—has been revolutionary. It has allowed the orthodontic practice to take control and fabricate aligners in-office, on their own schedule. But it wasn’t the 3D printer alone that facilitated this. Along the way, additional innovations were needed—chief among them the thermoforming plastic material. And now, these materials are further evolving with a new material that allows for direct 3D-printed aligners. Orthodontic Products Chief Editor Alison Werner spoke to Ki Beom Kim, DDS, PhD, the Dr Lysle Johnston Endowed Chair in Orthodontics, and the program director in the orthodontic department at the Center for Advanced Dental Education at Saint Louis University, on a recent podcast episode about a new material that allows for direct 3D-printed aligners.
    Kim and his colleagues have spent the last 3 years testing the Direct Aligner photopolymer material from the South Korean 3D printing material company Graphy. Their findings were recently published in Progress in Orthodontics. The team found that controlling material dimensions, structure, and properties of aligners directly—compared to thermoforming plastic sheets—has the potential to make the process of tooth movement faster, less wasteful, and more precise.

    • “If you have a 3D printer, you can now directly print this aligner without having [a] model, without going through the thermoforming process,” said Kim, adding that, with this new FDA approved material, the in-office lab can skip several steps in the current manufacturing workflow, including cutting out the aligners and polishing before delivery to the patient.
    • What’s more, according to Kim, with a direct printed aligner, the clinician can more precisely control the thickness and insert bumps as needed. Kim shared that he and his team found that when the orthodontist can control the thickness they can “control the geometric inside of the aligner.” That, and the ability to add bumps, creates a huge opportunity for the orthodontist because it helps reduce the need for attachments, he said.

    For Kim, the shape memory polymer used to make the material is very interesting.

    • He says it somewhat mimics the behavior of NiTi wire. The difference being that a NiTi wire can be exposed to cold temperature to become more flexible, while this Direct Aligner material becomes totally flexible when placed in warm/hot water. The advantage of this shape memory, according to Kim, is that the patient can maintain the shape—and thus the forces—of the aligner at home. Kim points out that patients remove their aligner up to 10 to 20 times a day to eat. “So think about the plastic deformation” every time they remove the aligner, said Kim. But with this material and some warm water, the shape can be restored. Kim uses the analogy of a deformed plastic Coke bottle. Once it’s deformed, it’s not going back to its original shape. But with this material, he can advise patients to put their aligner in warm water at the end of the day if they notice it’s not tight enough. “It will go back to the original shape so they can maintain [a better fit] every day,” he added.

    Now when it comes to forces, Kim shares he has been able to apply bigger activations per aligner, thus saving time in treatment and decreasing the number of aligners over the course of treatment. With traditional thermoforming plastics, Kim points out, something like a .5 mm activation per aligner can create a force level that causes the patient too much discomfort and even pain. But with this material, Kim can do that.

    • “I’m constantly putting .5 mm activations and even 5° rotation per aligner, and then have patients wear [the aligner] just a little bit longer—maybe 2 weeks. Sometimes we go longer,” said Kim, adding that with a standard activation of .25 mm per aligner, to move 1 mm you need four aligners. “But if I can put .5 mm activation per aligner [and] have them wear [it] for 2 weeks, then I need only two aligners.”

    In this episode, Kim also talks about the hardware requirements, including 3D printer compatibility with the material needed, and the need for a specific type of curing machine. He also talks about the staging software needed to plan cases using direct 3D-printed aligners. What’s more, he talks about retention and his plans to test an on-site retainer-bending machine from YOAT, a medical technology manufacturer based in Seattle. OP

    Pathophysiology of Idiopathic Hypersomnia

    Pathophysiology of Idiopathic Hypersomnia

    While the pathophysiology of idiopathic hypersomnia is unknown, emerging science suggests that nighttime sleep dysfunction may contribute to daytime sleepiness in patients with idiopathic hypersomnia. A systematic review and meta-analysis that included 10 studies found that, on average, several sleep architecture hallmarks were different in patients with idiopathic hypersomnia relative to controls.

    • Total sleep time and percent of REM sleep were increased in patients with idiopathic hypersomnia compared with controls.
    • Sleep-onset latency and percent of slow-wave sleep were decreased in patients with idiopathic hypersomnia compared with controls.
    • Sleep efficiency and REM latency were similar between patients with IH and controls.

    In addition to nighttime sleep dysfunction, other physiological changes have been observed in some patients with idiopathic hypersomnia and theorized as possible contributors to its pathophysiology including:

    • Dysfunction of the GABAergic system
    • Autonomic system dysfunction
    • Altered functional or regional connectivity in the brain
    • Circadian system dysfunction
    • Dysfunction of energy metabolism

    This episode is produced by Sleep Review and is episode 5 of a 5-part series sponsored by Jazz Pharmaceuticals. Visit Jazzpharma.com and SleepCountsHCP.com for more information. In episode 5, listen as Sleep Review’s Sree Roy and neurologist-sleep specialist Isabelle Arnulf, MD, PhD, discuss:

    • Science doesn’t fully understand the pathophysiology of idiopathic hypersomnia. Research has revealed potential clues, however. For example, idiopathic hypersomnia is associated with changes in sleep staging and architecture. What does emerging science suggest are differences in nighttime sleep?
    • How might the arousal index differ in idiopathic hypersomnia versus in people without it, and why might that matter?
    • In addition to nighttime sleep dysfunction, other physiological changes have been observed in some patients with idiopathic hypersomnia and theorized as possible contributors to its pathophysiology. What is the GABAergic system and its possible role?
    • What are some emerging findings surrounding idiopathic hypersomnia and autonomic system dysfunction?
    • What is the evidence that supports the idea of altered functional or regional connectivity in the brain in people with idiopathic hypersomnia?
    • There were fascinating studies done on skin fibroblasts, suggesting that circadian period length may be different in people with idiopathic hypersomnia versus in people without it. What role might circadian rhythm dysfunction have in idiopathic hypersomnia?
    • What has science discovered about the possible role of dysfunction of energy metabolism in idiopathic hypersomnia?
    • What further research would you like to see conducted on the pathophysiology of idiopathic hypersomnia?

    Listen to Episode 1: Symptoms of Idiopathic Hypersomnia

    Listen to Episode 2: Diagnosis of Idiopathic Hypersomnia

    Listen to Episode 3: Differential Diagnosis of Idiopathic Hypersomnia

    Listen to Episode 4: Burden of Idiopathic Hypersomnia

    The Big Challenges Facing Clinical Labs

    The Big Challenges Facing Clinical Labs
    In this episode of Clinical Lab Chat, Chris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today, including workforce shortages, scaling lab operations, and reimbursement, along with some of their solutions, including increased automation, agnostic platforms, and more coherent reimbursement coordination with regulatory agencies.

    Burden of Idiopathic Hypersomnia

    Burden of Idiopathic Hypersomnia

    People with idiopathic hypersomnia face a significant disease burden. Idiopathic hypersomnia is associated with challenges that impact daily living activities, such as limitations at school, work, interpersonal relationships, and social activities. Various impairments include 

      • Impacts on attention and cognition, which can be characterized as “brain fog”
      • The burden of memory problems and a feeling of the mind going blank or making a mistake in a habitual activity

    Public health and safety are also impacted, as more severe causes of sleepiness can be cause for accidents. Management strategies may not address the underlying sleep dysfunction associated, resulting in suboptimal symptom management. Patient survey and registry data suggest patients continue to experience symptoms of idiopathic hypersomnia and residual disease burden. This episode is produced by Sleep Review and is episode 4 of a 5-part series sponsored by Jazz Pharmaceuticals. Visit Jazzpharma.com and SleepCountsHCP.com for more information. In episode 4, listen as Sleep Review’s Sree Roy and pulmonologist-sleep specialist Richard K. Bogan, MD, discuss: 

      • What are some limits that people with idiopathic hypersomnia can experience in their daily living activities?
      • How do people with idiopathic hypersomnia commonly describe "brain fog," and what are some of the real-life consequences it?
      • How does prolonged sleep inertia place a burden on the people with idiopathic hypersomnia who experience this symptom?
      • What do you see as the burden of idiopathic hypersomnia on public health and safety?
      • Beyond medications, how is idiopathic hypersomnia typically managed to control for symptoms as much as possible?
      • How do you determine when therapy for idiopathic hypersomnia has been optimized, and what symptoms may remain at this point?

    How Should we Tackle the STI Epidemic

    How Should we Tackle the STI Epidemic
    In the latest episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, has a wide-ranging discussion with Jeff Andrews, MD, FRCSC, vice president of Medical Affairs for BD, about BD’s recent STI health survey and what the findings mean for women’s health and their access to care. They also discuss the poor state of medical health education in the U.S., solutions that can help healthcare providers more efficiently test women for sexually transmitted infections, and how laboratorians can help improve testing rates.

    Mouth Taping During Sleep

    Mouth Taping During Sleep
    This episode also provides valuable advice for sleep techs dealing with patients wanting to use mouth tape during in-lab sleep studies. DeNike underlines the importance of ensuring patients have a healthy nasal passageway and clarifies the role of mouth tape as a supportive accessory, not a standalone treatment. This episode is sure to provide you with a deeper understanding of mouth taping during sleep, armed with expert advice and valuable insights, whether you're a sleep professional or someone simply interested in optimizing your sleep health. In this episode, we answer the questions:
    • What exactly is mouth taping during sleep?
    • How has the practice of mouth taping during sleep evolved in popularity over the years?
    • Is there any evidence that mouth taping is useful for healthy sleepers, that is, people without any sleep disorders?
    • Is there any evidence that mouth taping is useful for people with any sleep disorders, perhaps as an add-on to a device such as an oral appliance for sleep apnea?
    • What dangers are associated with mouth taping during sleep?
    • What is your advice to sleep techs for how to handle the situation of an in-lab sleep study patient who wants to use mouth taping during an in-lab sleep study?
    • What is your evidence to sleep medicine professionals if their patients confide in them that they using mouth tape, either with or without their prescribed device, to treat a sleep disorder?

    Differential Diagnosis of Idiopathic Hypersomnia

    Differential Diagnosis of Idiopathic Hypersomnia
    The differential diagnosis of idiopathic hypersomnia is challenging for several reasons. Its hallmark symptom, excessive daytime sleepiness, is a common symptom of many disorders, and ts ancillary symptoms also overlap with other disorders. A lack of validated biomarkers adds to the challenge. Assessing for key symptoms and medical history is a first step to help identify patients presenting with excessive daytime sleepiness who may have idiopathic hypersomnia. From there, there are several symptoms that can differentiate the diagnosis of idiopathic hypersomnia from other disorders such as sleep apnea or narcolepsy. These include:
      • Sleep inertia: sleep inertia is common in patients with idiopathic hypersomnia but can also be reported by individuals with mood disorders
      • Patients with idiopathic hypersomnia often find naps to be long and unrefreshing, while patients with narcolepsy generally find short naps to be restorative
      • If a patient has prolonged nighttime sleep, long sleeper syndrome should be considered; in contrast to patients with idiopathic hypersomnia, long sleepers feel refreshed and do not have daytime sleepiness and difficulty awakening if they are allowed to sleep as long as they need
      • Cognitive complaints, often described as "brain fog" are common symptoms of idiopathic hypersomnia but also can occur in patients with various sleep-wake disorders (including narcolepsy type 1 and insufficient sleep syndrome)
    This episode is produced by Sleep Review and is episode 3 of a 5-part series sponsored by Jazz Pharmaceuticals. Visit Jazzpharma.com and SleepCountsHCP.com for more information. In episode 3, listen as Sleep Review’s Sree Roy and neurologist-sleep specialist Yves Dauvilliers, MD, PhD, discuss:
      • Idiopathic hypersomnia can be particularly challenging to diagnose because of its lack of specific biomarkers, as well as its symptoms resembling those of other disorders. How do you differentiate idiopathic hypersomnia from hypersomnias of a specific cause, such as narcolepsy type 1 and type 2, insufficient sleep syndrome, or hypersomnia due to a neurodegenerative disease?
      • A minority of people simply need to sleep longer than most, even 10 hours or more, to feel refreshed. How do you determine if that applies to a given person, who may not have a sleep disorder at all?
      • How do you differentiate idiopathic hypersomnia from hypersomnia comorbid to psychiatric disorders, such as prolonged sleep time tied to depression?
      • At what point in ruling out other disorders should objective sleep testing, such as polysomnography and multiple sleep latency testing, be done?
      • Why is idiopathic hypersomnia sometimes confused with sleep-breathing disorders? When would you recommend a CPAP trial to address possible apneas, hypopneas, or respiratory-event related arousals?
      • How do you distinguish chronic fatigue syndrome from idiopathic hypersomnia?
    Listen to Episode 1: Symptoms of Idiopathic Hypersomnia Listen to Episode 2: Diagnosis of Idiopathic Hypersomnia

    The Hidden Risks of Obstructive Sleep Apnea

    The Hidden Risks of Obstructive Sleep Apnea
    Sleep specialist Indira Gurubhagavatula, MD, MPH, is our guest and chair of the Count on Sleep Tool Development and Surveillance Workgroup for The Obstructive Sleep Apnea: Indicator Report, which provides an in-depth analysis of the symptoms, risk factors, prevalence, and burden of obstructive sleep apnea and serves as a resource for both the public and the health care communities on the importance of diagnosis and long-term treatment. Gurubhagavatula and Sleep Review editor Sree Roy discuss the hidden risks of obstructive sleep apnea—the mortality and morbidity that makes obstructive sleep apnea (OSA, for short) particularly insidious. We discuss obstructive sleep apnea’s links to vehicle crashes, treatment-resistant hypertension, impaired brain function, erectile dysfunction and female sexual dysfunction, type 2 diabetes, and early death. We also discuss treatments for obstructive sleep apnea and how healthcare providers can screen patients to intervene early for patients at risk of obstructive sleep apnea. Specifically, this episode about the hidden risks of obstructive sleep apnea provides answers to:
    • What is obstructive sleep apnea, also known as OSA for short?
    • What do you think is the most troubling risk of not treating obstructive sleep apnea?
    • How has treatment-resistant hypertension been linked to OSA?
    • How can the impaired brain function linked to OSA manifest in patients?
    • What evidence is out there that erectile dysfunction and female sexual dysfunction can be tied to OSA?
    • How has obstructive sleep apnea been linked to diabetes?
    • The worst link in my view is that obstructive sleep apnea has been linked to an earlier death. Why is that?
    • Treatment of sleep apnea typically involves a device, such as a CPAP machine or an oral appliance, though surgery can be an option for some patients. Is there any evidence that treating OSA can alleviate some of sleep apnea morbidities or mortality?
    • With all of this evidence in mind, what should healthcare providers do to help identify patients who are likely to have obstructive sleep apnea?
    • What should any patients listening to this podcast do if they think they have symptoms of obstructive sleep apnea?

    Diagnosis of Idiopathic Hypersomnia

    Diagnosis of Idiopathic Hypersomnia
    The International Classification of Sleep Disorders, 3rd ed, lists the criteria needed for a diagnosis idiopathic hypersomnia.

    For a diagnosis of idiopathic hypersomnia, the following must be met:
    o excessive daytime sleepiness daily for at least 3 months
    o cataplexy is not present
    o multiple sleep latency test (MSLT) shows <2 or no sleep-onset REM periods (SOREMPs) if the rapid eye movement (REM) latency on the preceding polysomnogram (PSG) was ≤15 minutes
    o insufficient sleep syndrome is ruled out

    And at least one of the following:
    o MSLT shows a mean sleep latency of ≤8 minutes
    o Total 24-hour sleep time is ≥660 minutes (typically 12-14 hours) on 24-hour PSG monitoring (performed after correction of chronic sleep deprivation), or by wrist actigraphy in association with a sleep log (averaged over at least 7 days with unrestricted sleep)
    o Hypersomnolence and/or MSLT findings are not better explained by another sleep disorder, other medical or psychiatric disorders, or use of drugs or medication

    Additional supportive features can include:
    o Severe and prolonged sleep inertia
    o High sleep efficiency (>90%)
    o Long, unrefreshing naps (>1 hour)

    This episode is produced by Sleep Review. It is episode 2 of a 5-part series sponsored by Jazz Pharmaceuticals. Visit Jazzpharma.com and SleepCountsHCP.com for more information.

    In episode 2, listen as Sleep Review’s Sree Roy and neurologist-sleep specialist Margaret S. Blattner, MD, PhD discuss:
    o What are some barriers to diagnosing idiopathic hypersomnia?
    o Objective sleep testing is needed to diagnosis idiopathic hypersomnia. What polysomnography and multiple sleep latency test findings support a diagnosis of idiopathic hypersomnia?
    o What are some best practices for conducting a PSG and MSLT for a patient with suspected idiopathic hypersomnia?
    o What are some of the additional commonly seen supportive features of idiopathic hypersomnia?

    Medical Device Cybersecurity - How It’s Impacting Health Systems and the BMETs Serving Them

    Medical Device Cybersecurity - How It’s Impacting Health Systems and the BMETs Serving Them
    Join 24x7 chief editor Keri Forsythe-Stephens as she sits down with cybersecurity expert Scott Trevino to delve into the pressing issue of medical device cybersecurity. As senior vice president for cybersecurity at comprehensive clinical asset management service provider TRIMEDX, Trevino shares how he stays at the forefront of cybersecurity trends, with a keen focus on medical devices. Moreover, he reveals his pivotal role in developing cutting-edge cybersecurity solutions for TRIMEDX's clients, aiming to fortify their defense against evolving cyber threats.

    The podcast provides a comprehensive analysis of the current state of healthcare cybersecurity. Trevino points out that the healthcare industry, particularly medical devices, has lagged significantly behind other critical infrastructure sectors in terms of cybersecurity maturity. He cites alarming statistics, showcasing a staggering 200% increase in ransomware attacks in the past five years.

    He also highlights the severe impact of cyberattacks on patient care, clinicians, and HTM professionals. Trevino emphasizes that delays in treatment due to cyber incidents result in a 30%-plus increase in direct patient harm or complications, profoundly affecting patient outcomes.

    The conversation turns to the legislation and regulations surrounding medical device cybersecurity. And Trevino discusses the recent legislative actions empowering the U.S. FDA to enforce cybersecurity requirements on medical device manufacturers. However, he warns against relying solely on legislation and encourages healthcare providers to proactively assess and improve their cybersecurity practices.

    Finally, Trevino shares how TRIMEDX has launched a revolutionary cybersecurity solution called Vigilor. This product provides comprehensive cybersecurity services to hospitals, even those without TRIMEDX's clinical engineering program. Scott discusses how Vigilor works collaboratively with existing biomed teams and IT departments to assess risks and drive improvement.

    To learn more about Vigilor from TRIMEDX or to request a Cyber Current State Assessment, visit trimedx.com/cybersecurity.
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io